Literature DB >> 16597409

[Voltage-dependent calcium channels at the heart of pain perception].

Norbert Weiss1, Michel De Waard.   

Abstract

Voltage-dependent calcium channels represent a major pathway of calcium entry into neurons, where they participate actively to cell excitability and to the molecular processes of synaptic transmission. For that reason, they have been the direct or indirect pharmacological targets of analgesics and this long before their implication in the physiology of nociception had been demonstrated. These last years, the still more refined molecular characterization of these channels and their associated regulatory subunits and the demonstration of their implication in nociceptive processes indicates that these structures are prime pharmacological targets for the management of pain. Herein, we detail the recent breakthroughs on calcium channel structure, function and pharmacology, review the implication of calcium channels in the transmission of nociception, and evaluate their importance as targets for the treatment of pain perception. The search for specific inhibitors of voltage-dependent calcium channels appears as a prelude to the development of new promising analgesic molecules.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16597409     DOI: 10.1051/medsci/2006224396

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


  3 in total

1.  The analgesic effect of trans-resveratrol is regulated by calcium channels in the hippocampus of mice.

Authors:  Weijie Wang; Yingcong Yu; Jing Li; Lin Wang; Zhi Li; Chong Zhang; Linlin Zhen; Lianshu Ding; Gang Wang; Xiaoyang Sun; Ying Xu
Journal:  Metab Brain Dis       Date:  2017-06-12       Impact factor: 3.584

2.  Resveratrol-induced antinociception is involved in calcium channels and calcium/caffeine-sensitive pools.

Authors:  Xiaoyu Pan; Jiechun Chen; Weijie Wang; Ling Chen; Lin Wang; Quan Ma; Jianbo Zhang; Lichao Chen; Gang Wang; Meixi Zhang; Hao Wu; Ruochuan Cheng
Journal:  Oncotarget       Date:  2017-02-07

3.  Discovery of a Novel Non-Narcotic Analgesic Derived from the CL-20 Explosive: Synthesis, Pharmacology, and Target Identification of Thiowurtzine, a Potent Inhibitor of the Opioid Receptors and the Ion Channels.

Authors:  Stephanie Aguero; Simon Megy; Valeria V Eremina; Alexander I Kalashnikov; Svetlana G Krylova; Daria A Kulagina; Ksenia A Lopatina; Mailys Fournier; Tatyana N Povetyeva; Alexander B Vorozhtsov; Sergey V Sysolyatin; Vadim V Zhdanov; Raphael Terreux
Journal:  ACS Omega       Date:  2021-05-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.